<p><h1>Drug-Coated Balloons Market Insights, Market Players and Forecast Till 2031</h1></p><p><strong>Drug-Coated Balloons Market Analysis and Latest Trends</strong></p>
<p><p>Drug-coated balloons (DCBs) are innovative medical devices that are used in the treatment of vascular diseases. They consist of a balloon catheter coated with a drug, typically an anti-proliferative agent, which is released into the vessel wall during angioplasty. The drug helps to prevent the re-narrowing of the blood vessels, known as restenosis, that often occurs after angioplasty procedures.</p><p>The drug-coated balloons market is expected to experience significant growth over the forecast period. The market growth analysis reveals a CAGR of 6.2%, indicating a rising demand for these devices. Several factors contribute to this growth, including the increasing prevalence of cardiovascular diseases, technological advancements in balloon catheter design, and a growing preference for minimally invasive procedures.</p><p>One of the latest trends in the drug-coated balloons market is the development of next-generation DCBs. These newer iterations aim to improve drug delivery efficiency and reduce the risk of restenosis further. Manufacturers are investing in research and development to enhance drug-eluting coating technologies, optimize balloon design, and improve mechanical properties of these devices.</p><p>Another emerging trend is the expanding application of DCBs beyond the treatment of coronary artery diseases. Drug-coated balloons are increasingly being used in the treatment of peripheral artery diseases, such as peripheral arterial disease (PAD) and critical limb ischemia (CLI). The potential of DCBs in treating an even broader range of vascular conditions presents a substantial growth opportunity for the market.</p><p>In conclusion, the drug-coated balloons market is anticipated to expand at a CAGR of 6.2% during the forecast period. Factors such as the rising prevalence of cardiovascular diseases, advancements in balloon catheter design, and expanding applications in peripheral artery diseases contribute to this market growth. The ongoing research and development efforts to enhance drug-eluting coating technologies and optimize balloon design further drive the market's evolution.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1639602">https://www.reliableresearchreports.com/enquiry/request-sample/1639602</a></p>
<p>&nbsp;</p>
<p><strong>Drug-Coated Balloons Major Market Players</strong></p>
<p><p>The drug-coated balloons (DCBs) market is highly competitive, with several key players operating in the industry. Some of the prominent players in the market include Medtronic, BD, B. Braun Melsungen, Koninklijke Philips, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group, BioMed, Concept Medical, Cardionovum, Endocor, Hexacath Sverige, iVascular SLU, Minvasys, MedAlliance, QT Vascular, RD Global-Invamed, SurModics, Terumo, and Wellinq.</p><p>Medtronic is a leading player in the DCBs market, offering a wide range of innovative products. The company has a strong presence in the market due to its extensive distribution network and strategic acquisitions. Medtronic's market growth has been driven by its focus on research and development, introducing advanced DCBs such as IN.PACT Admiral and IN.PACT AV. The company has witnessed steady revenue growth, with total sales of approximately $31 billion in the fiscal year 2020.</p><p>Boston Scientific is another major player in the DCBs market, known for its groundbreaking technologies. The company has a diverse product portfolio and a global presence. Boston Scientific's growth in the DCBs market can be attributed to its focus on technological advancements, product launches, and strategic collaborations. The company recorded total sales of around $10.7 billion in 2020.</p><p>Another significant player is Terumo, a Japanese medical device company known for its high-quality products. Terumo's DCBs, such as RYUREI, have gained popularity due to their efficacy and safety. The company has been expanding its market presence through acquisitions and partnerships. Terumo reported consolidated net sales of approximately $6 billion in the fiscal year 2020.</p><p>The market for DCBs is expected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of cardiovascular diseases and a growing aging population. According to a report by Meticulous Research, the global drug-coated balloons market is projected to reach $1.8 billion by 2027.</p><p>In conclusion, the drug-coated balloons market is highly competitive, with players such as Medtronic, Boston Scientific, and Terumo leading the way. These companies have achieved market growth through their focus on innovation, product launches, and strategic partnerships. The market is expected to grow rapidly in the future, offering immense opportunities for these players.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Drug-Coated Balloons Manufacturers?</strong></p>
<p><p>The drug-coated balloons market has witnessed significant growth in recent years and is expected to continue growing at a steady pace in the future. The market is driven by factors such as the increasing prevalence of cardiovascular diseases, rising demand for minimally invasive procedures, and advancements in drug-coating technologies. Additionally, the growing geriatric population, which is more susceptible to cardiovascular diseases, is also contributing to the market's growth. Market players are focusing on developing innovative products and expanding their geographical presence to gain a competitive edge. With ongoing research and the introduction of new product offerings, the drug-coated balloons market is expected to flourish in the coming years.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1639602">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1639602</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Drug-Coated Balloons Market Analysis by types is segmented into:</strong></p>
<p><ul><li>DCB for Peripheral Artery Disease</li><li>DCB for Coronary Artery Disease</li><li>DCB for Other Indications</li></ul></p>
<p><p>Drug-coated balloons (DCBs) are a type of medical device used in the treatment of various artery diseases. In the case of peripheral artery disease (PAD), DCBs are designed to help open up narrowed or blocked blood vessels in the legs or other peripheral areas. Similarly, for coronary artery disease (CAD), DCBs are employed to expand constricted arteries in the heart. Additionally, DCBs can be used for other indications, such as in the treatment of blocked or narrowed blood vessels in the lungs or kidneys. These balloons are coated with medications that help prevent the re-narrowing of the arteries, enhancing the effectiveness of the procedure.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1639602">https://www.reliableresearchreports.com/purchase/1639602</a></p>
<p>&nbsp;</p>
<p><strong>The Drug-Coated Balloons Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals</li><li>Cardiac Catheterization Labs</li><li>ASCs</li></ul></p>
<p><p>Drug-coated balloons are commonly used in hospitals, cardiac catheterization labs, and ambulatory surgical centers (ASCs) for various medical procedures. In hospitals, these balloons are utilized for treating patients with narrowed or blocked blood vessels, such as the ones in the heart or legs. Cardiac catheterization labs perform minimally invasive cardiac procedures, and drug-coated balloons aid in reducing artery blockages. Similarly, ASCs utilize these balloons for addressing vascular issues without the need for extensive surgeries. In all these settings, drug-coated balloons provide a targeted drug delivery method, promoting efficient and precise treatment.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Drug-Coated Balloons Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The drug-coated balloons market is anticipated to witness significant growth in the North America (NA), Asia-Pacific (APAC), Europe, United States (USA), and China regions during the forecast period. North America is expected to dominate the market with the highest market share percentage, owing to the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. Europe is projected to be the second-largest market, driven by the growing geriatric population and the increasing demand for advanced treatment options. The APAC region is expected to exhibit substantial market growth due to improving healthcare infrastructure, rising healthcare expenditure, and growing awareness about the benefits of drug-coated balloons. In the USA, the market share is estimated to be significant, driven by the increasing incidence of peripheral artery diseases and the strong presence of key market players. On the other hand, China is expected to witness rapid growth in the drug-coated balloons market, primarily fueled by the large patient population, rising healthcare investments, and the growing prevalence of chronic diseases.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1639602">https://www.reliableresearchreports.com/purchase/1639602</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1639602">https://www.reliableresearchreports.com/enquiry/request-sample/1639602</a></p>
<p><strong></strong></p>
<p>Check more reports on https://www.reliableresearchreports.com/</p>